SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense community speculation and record-breaking trading volume, with investors closely watching a recent counter-drone contract award and anticipating a pivot for the defense technology sector. The discourse remains highly polarized, as bulls point to fundamental growth opportunities while bears express concern over heavy short interest and past equity-related dilution.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is generating significant community conversation following a court ruling in favor of its subsidiary, PriceRunner, against Google, which has led many investors to anticipate improved balance sheet strength and potential future growth. While some traders are expressing frustration over volatility and short-term price action, long-term investors are focused on the firm's expanding presence in the fintech sector and its strategic pivot toward becoming a comprehensive financial super app.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is trending as investors debate whether the stock is primed for a breakout toward double digits following recent analyst upgrades and signs of institutional accumulation. While some in the community highlight bullish technical indicators and compare the potential growth trajectory to other major brokerage stocks, skeptics remain wary of past volatility and price suppression, leading to active debates over short-squeeze potential versus long-term fundamental performance.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is experiencing increased attention following the successful early enrollment completion of its Phase 3 APPROACH study for the MDD treatment HLP003, which holds FDA Breakthrough Therapy Designation. Community discourse remains divided, however, as investors weigh the stock's clinical progress and sector tailwinds against recurring concerns regarding executive turnover, cash burn, and the potential for shareholder dilution.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digital is experiencing high volatility as investors weigh the stock's significant long-term potential in the expanding AI data center sector against broader market rotation and profit-taking. While community sentiment remains highly bullish on the company's long-term execution and power-focused business model, shares are currently tracking sector-wide downward pressure driven by concerns over hyperscaler capacity and general profit-taking across digital infrastructure.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple's XRP is trending as the community debates potential legislative progress on the Crypto Clarity Act and its expected impact on institutional liquidity. Investors are actively discussing the token's ability to decouple from Bitcoin while weighing concerns over market stagnation and supply dynamics.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines Inc. is trending as investors rotate capital into domestic drone manufacturing and defense technology, driven by ongoing discussions around potential U.S. government funding and national security supply chain requirements. The community remains highly focused on the company's strategic manufacturing expansion in Florida and its pivotal role as a supplier for broader drone-defense ecosystems, with active debate regarding potential catalysts from defense policy updates and the stock's recent volatility.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

General Motors is trending following a robust earnings report that beat market expectations on both top and bottom lines, leading the company to raise its full-year guidance. The community is actively discussing GM's strategic shift toward internal combustion engines and hybrids, its recent partnership with Lockheed Martin for defense manufacturing, and the potential impact of ongoing tariff policies on its long-term profit margins.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is trending as investors react to the company's first successful shipments under its defense contract and the wet commissioning of its new Montana flotation mill. While the community remains divided over the stock's recent volatility and broader sector pressure, discussions are centered on the company's strategic move toward full vertical integration and its role as a key supplier for U.S. defense needs.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is capturing market attention as the quantum sector receives heightened government focus, including recent executive orders aimed at accelerating national leadership and research. While retail investors remain active in discussing price volatility and potential technical breakouts, community sentiment is sharply divided between those tracking the stock's support levels for long-term growth and others cautioning about insider selling and the company's path to commercial profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

RHHBY's Gazyva Gets FDA Priority Review for Label Expansion 

Roche wins FDA Priority Review for Gazyva in primary membranous nephropathy, with a decision due by November 2026 after positive phase III data.

Company News for July 13, 2026

Companies In The Article Are:WDFC,DAL,NRIX and FCX

Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates

Nurix Therapeutics (NRIX) delivered earnings and revenue surprises of -10.96% and -36.76%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs

A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs PR Newswire SAN FRANCISCO, July 6, 2026 Issued on...

Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug 

RHHBY announces positive phase III Krascendo 1 results for divarasib in KRAS G12C NSCLC, showing PFS and OS gains versus approved inhibitors.

Earnings Preview: Nurix Therapeutics, Inc. (NRIX) Q2 Earnings Expected to Decline

Nurix Therapeutics (NRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wall Street Analysts Believe Nurix Therapeutics (NRIX) Could Rally 29.23%: Here's is How to Trade

The mean of analysts' price targets for Nurix Therapeutics (NRIX) points to a 29.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease

Roche won FDA priority review for Enspryng in thyroid eye disease, with a decision date in October and phase III data backing the filing.

Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value

Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value...

Nurix Stock Up 29% in a Month: Here's What You Should Know

NRIX rallies on its collaboration with Roche for bexobrutideg, featuring a $700 million upfront payment and potential milestone payouts of up to $2.3 billion.

Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in Brisbane, CA.

Nurix Therapeutics Inc

NRIX Stock Surges Nearly 70% Premarket Today – Roche And Nurix’s Blood Cancer Drug Collaboration Can Tap A $41B Market

Equity

Neutral Sentiment

Too early to tell

Memory stocks have been under significant selling pressure in recent weeks. Is the selloff done? Cast your vote and drop your reasoning in the comments.

Is the pullback in memory stocks over? 
 
Explain your reasoning in the comments.

Current Price	$23.10
Prev Close	$22.71
Open	$22.76
Dividend Yield	0.00%
50-Day Moving Average	$19.02
Beta	1.63
Avg. Volume	3.77M
PE Ratio	-6.59

52-Week High	$25.09
52-Week Low	$8.20
Market Capitalization	$2.36B
EPS (Annual)	-$3.05
Price to Book	5.85
Revenue Per Employee	$264,921.14

Feed

News

Sentiment

Earnings

Fundamentals

Info

NRIXNurix Therapeutics Inc

Latest NRIX News